Furthermore, the specific ATM variant p.Leucine2307Phenyloalanine, found in 3% of patients with CLL, correlates with a three-fold higher occurrence of somatic 11q deletion and displays reduced function in cellular assays [133], DNA damage and secondary primary malignancy. This evidence concerns the gene ATM and B-cell chronic lymphocytic leukemia.